Queen Mary University of London

Higher Educationqmul.ac.uk

Queen Mary University of London is a Russell Group public research university in London delivering undergraduate, postgraduate, and research degrees across medicine, science, engineering, humanities, and social sciences to a student body from 170+ countries, funded through tuition, research grants, NHS partnerships, and spin-out commercialization.

Company typePublic
Founded1785
HeadquartersLondon, United Kingdom
Headcount5,001–10,000
GTM typeB2C
OfferingServices

What Queen Mary University of London does

Queen Mary University of London (QMUL) is a Russell Group public research university established by Royal Charter (RC000710) and headquartered in London, with origins traced to 1785 and 5,001-10,000 employees. It is ranked 101st globally by U.S. News and 103rd by QS 2027, and 31st globally for research quality (THE 2026). The university delivers undergraduate, postgraduate taught, and research degree programs across humanities, social sciences, science, engineering, medicine, dentistry, and law, with a student body drawn from 170+ countries making it one of the most internationally diverse institutions in the world. Operations span multiple London campuses (Mile End, Whitechapel, Charterhouse Square, plus a new Barking dental training hub), with international joint programs in China and Brazil.

The research portfolio spans cardiovascular digital twins, HPV vaccine impact studies, quantum computing (room-temperature carbon-based qubits with electron spin lifetimes exceeding 0.4 microseconds), soft robotics, and sustainable energy technologies such as a bio-inspired integrated solar reactor and a biodegradable moisture-electric generator. The university's AI/ML capabilities are embedded across multiple modalities — predictive analytics (Obscore, PancRISK), computer vision (RipenAI), and multimodal sensing (LSTM tactile comparisons) — and the £18.9 million PharosAI consortium with 10x Genomics is building one of the world's largest multimodal cancer datasets. Strategic partnerships include Barts Health NHS Trust, Cancer Research UK, Schneider Electric, MCatalysis, Lucideon, Archer Materials, Imperial College London, Cardiff University, and the University of Cambridge.

The revenue model is diversified across tuition fees (annual billing for UG and PG, deposits required for PG), research grants and consortium funding (EPSRC, Defra, UKRI, Cancer Research UK, Research Ventures Catalyst), NHS clinical income via Barts Health, industry partnerships and consulting, and commercial spin-outs such as Procyon Diagnostics. International student scholarships of up to £12,000 and British Council Women in STEM scholarships valued at a minimum of £40,000 support recruitment. The university holds GDPR, ISO 27001, and PCI DSS 4.0.1 compliance posture and is governed by its Royal Charter with no parent company.

Queen Mary University of London firmographics

Firmographics

Name: Queen Mary University of London
Legal name: Queen Mary University of London
Website: https://qmul.ac.uk
Company type: Public
Founded year: 1785
Operating status: Operating
Headcount range: 5,001–10,000 employees
Short description: Queen Mary University of London is a Russell Group public research university in London delivering undergraduate, postgraduate, and research degrees across medicine, science, engineering, humanities, and social sciences to a student body from 170+ countries, funded through tuition, research grants, NHS partnerships, and spin-out commercialization.
Ownership category
akta.pro rank

Queen Mary University of London industry classification

Industry

Product category: Higher Education
NAICS: Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC: Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro primary industry: Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA)
akta.pro secondary industries: Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Management Research Institutes & Doctoral (PhD/DBA) Programs (EDAHAHAO), Business & Management Research Universities (EDAHABAE)

Keywords

Higher education services
Academic degree programs
University research institutes
Postgraduate taught degrees
Clinical medical training

Where Queen Mary University of London is headquartered

Location

Headquarters

HQ city: London
HQ country: United Kingdom
HQ region: Europe

Markets served

Queen Mary University of London business model

Business model

GTM type: B2C
Offering type: Services
Cost components: Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Pricing tiers

Model	Billing	Price
Subscription	Annual	Undergraduate tuition fees
Subscription	Annual	Postgraduate tuition fees
Other	One time/ perpetual license	International student scholarships
Other	Multi-year contract	British Council Women in STEM scholarships

Distribution channels4 records

Marketing channels7 records

Queen Mary University of London product offering

Product offering

Core offering

Queen Mary University of London delivers undergraduate, postgraduate taught, and postgraduate research degree programs across humanities, social sciences, science, engineering, medicine, dentistry, and business. It also operates specialised teaching clinics (notably the Institute of Dentistry with NHS dental care) and runs major research institutes such as the Barts Cancer Institute, Blizard Institute, and William Harvey Research Institute. The university monetises tuition fees, UK government research grants, NHS clinical training funding, and commercial research partnerships.

Product overview

Queen Mary University of London is a Russell Group university offering comprehensive higher education across undergraduate, postgraduate, and research degree programs in disciplines including humanities, social sciences, medicine, dentistry, science, engineering, and business. The university's product portfolio includes academic degree programs as its core offering, supplemented by specialized research institutes (Digital Environment Research Institute, Precision Healthcare University Research Institute), dental training clinics, and emerging technology spin-offs. Research commercialization efforts include the PancRISK cancer detection test developed by Procyon Diagnostics, the Obscore AI health risk prediction tool developed in collaboration with Cambridge, and microwave-catalytic medical waste recycling technology. The institution operates across multiple London campuses (Mile End, Whitechapel, Charterhouse Square) and internationally through partnerships in Malta, Paris, and China.

Differentiator

Problem solved

Functional benefit

Brands

Queen Mary Institute of Dentistry: Dental institute offering postgraduate programmes and dental care services.
Barts Cancer Institute
Blizard Institute
William Harvey Research Institute

Products and services

Academic Degree Programs (Undergraduate, Postgraduate, PhD)

Quantifiable outcome

Zero cervical cancer deaths among women aged 20-24 in England between 2020-2024 attributed to HPV vaccination program
+4 more outcomes

Companies that use Queen Mary University of London

Customer profile

Ideal customer profiles3 records

Queen Mary University of London technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature16 records

Queen Mary University of London partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered minor and core.

ValiRx PLCminorStrategic or Co-development Partner · 22 June 2026Research collaboration involving Professor Cleo Bishop's group at Queen Mary for technology evaluation funded by £50,000 Queen Mary Impact Fund grant. Collaboration concluded without technology licensing.
University of Dundee Drug Discovery UnitminorStrategic or Co-development Partner · 22 June 2026Collaboration with ValiRx for technology evaluation involving Queen Mary researchers, with IP reverting to both Dundee and Queen Mary after evaluation concluded.
University of São PaulocoreStrategic or Co-development Partner · 21 May 2026Research collaboration visit focused on responsible AI, genomics, public health, sensing technologies, sustainable development, and social inclusion. Part of UK-Brazil research partnership.
Universidade Federal do Rio de JaneirocoreStrategic or Co-development Partner · 21 May 2026Research collaboration visit in Brazil focused on responsible AI, genomics, public health, sensing technologies, sustainable development, and social inclusion.
Butantan InstitutecoreStrategic or Co-development Partner · 21 May 2026Brazilian research institution collaboration focused on public health and biomedical research partnerships.
MCatalysis, Inc.coreStrategic or Co-development Partner · 19 May 2026Deep-tech partnership to develop microwave-catalytic technology for converting medical waste into chemicals and synthetic fuels. Funded by £1.7M EPSRC and Defra grant. Project aims for 95% reduction in waste volume and 80% cost reduction compared to current incineration methods, supporting UK's transition to net zero economy.
Barts Health NHS TrustcoreStrategic or Co-development Partner · 19 May 2026Clinical partner in medical waste recycling research project, providing real-world healthcare waste management context and validation opportunities.
Cardiff UniversityminorStrategic or Co-development Partner · 19 May 2026Research partner in the EPSRC/Defra medical waste upcycling consortium.
Imperial College LondonminorStrategic or Co-development Partner · 19 May 2026Research partner in the EPSRC/Defra medical waste upcycling consortium.
LucideoncoreStrategic or Co-development Partner · 18 May 2026Partnership with Queen Mary's School of Engineering and Materials Science to develop in vitro cell biology laboratory in the UK. The collaboration creates global footprint for medical device testing, supporting biocompatibility testing and regulatory compliance services.
Saffron Grange VineyardminorStrategic or Co-development Partner · 12 April 2026Industry partner hosting field trials of RipenAI grape ripeness sensor technology during harvest season.
Barking and Dagenham CouncilcoreStrategic or Co-development Partner · 13 November 2025£4.1M investment partnership to open academic dental training centre in Barking, East London. Centre will train 130 dental students annually, provide NHS dental care to over 5,000 patients, and create approximately 44 local jobs.
Archer Materials LimitedcoreStrategic or Co-development Partner · 15 October 2025Collaboration on carbon-based qubit technology development, contributing to room-temperature quantum computing research with electron spin lifetime achievements.
Schneider ElectriccoreStrategic or Co-development Partner · 26 June 2025Partnership to modernize Queen Mary's data centre and enable waste heat reuse for campus-wide heating systems. The project uses Schneider's EcoStruxure Row Data Centre solution to integrate power, cooling, and management systems, reducing carbon emissions and cutting heating costs while supporting research computing including GridPP/CERN processing.
HaleoncoreStrategic or Co-development PartnerHealth giant partnership to deliver doctoral training programs, supporting next generation of health researchers.
MCatalysis (France facility)minorStrategic or Co-development PartnerPilot-scale validation of medical waste recycling technology to be conducted at MCatalysis's facility in Lyon, France.
British CouncilcoreGTM or Marketing PartnerPartner for Women in STEM scholarships program offering 25 fully funded postgraduate places at Queen Mary for women from South Asia, valued at minimum £40,000 each.
University of CambridgecoreStrategic or Co-development PartnerCollaborated with Queen Mary to develop Obscore AI tool for predicting obesity-related health risks using UK Biobank data.
Broad InstituteminorStrategic or Co-development PartnerCollaborated on radiation and gene therapy combination research published in Cancer Cell journal for solid tumor treatment.
CIMA/Cancer Center Universidad de NavarracoreStrategic or Co-development PartnerLead research institution on radiation and IL-12 gene therapy combination with Queen Mary contributing expertise, planning Phase I clinical trials for 2027.
10x GenomicscoreTechnology or IntegrationPartnership to build one of world's largest multimodal cancer datasets using Xenium spatial platform, backed by £18.9 million UK government funding through PharosAI consortium.
PharosAIcoreStrategic or Co-development PartnerUK research consortium backed by £18.9 million from Research Ventures Catalyst, uniting four leading UK institutions including Queen Mary for AI-driven cancer research.

Recent moves8 records

Expansion highlights6 records

Queen Mary University of London competitors and assessment

Company assessment

Direct peers

University College London (UCL): Fellow Russell Group London research university with similar breadth across medicine, engineering, humanities, and social sciences. UCL is QMUL's closest direct competitor for London-based students, faculty, and grant funding.
Imperial College London: Russell Group London university with overlapping STEM, medicine, and materials science research. Imperial competes directly for QS ranking position, research grants, and corporate partnerships in engineering and life sciences.
King's College London: Russell Group London university with strong overlap in medicine, dentistry, and humanities. King's competes with QMUL on NHS-affiliated medical research, dental training, and central-London student recruitment.
University of Cambridge: Top-tier UK research university that co-developed QMUL's Obscore AI tool and competes for the same UKRI grant pool and international student talent. Highly comparable as a multi-disciplinary research institution.
University of Oxford: Premier UK research university competing with QMUL for top global rankings, international postgraduate students, and large-scale translational research funding.
London School of Economics and Political Science (LSE): London-based Russell Group institution with strong overlap in social sciences and humanities. Competes for the same postgraduate international cohort, particularly from South Asia and East Asia.
University of Edinburgh: Russell Group research university with comparable multi-disciplinary scope and a similar international student mix. Competes with QMUL for UK and EU research funding and league-table positioning.
University of Manchester: Large Russell Group research university with overlapping research strengths in materials science, cancer, and digital health. Comparable scale, international student base, and translational research pipeline.
University of Bristol: Russell Group university with comparable research portfolio in biomedical sciences, engineering, and social sciences. Competes for the same UKRI funding streams and Russell Group ranking positioning.

Regional players

University of Warwick: Russell Group university with strong STEM and social science research; geographically distinct from London but competes for the same UK postgraduate and international student pool and QS top-100 positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Queen Mary University of London compliance and trust

Trust signal

Compliance3 records

Queen Mary University of London financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Queen Mary University of London leadership team

Management profile

Number of profiles

Profiles16 records

Queen Mary University of London funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Queen Mary University of London M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Queen Mary University of London

What does Queen Mary University of London do?

Is Queen Mary University of London a public or private company?

Queen Mary University of London is a public company. It is classified as nonprofit foundation owned and is currently operating.

When was Queen Mary University of London founded?

Queen Mary University of London was founded in 1785. It employs 5,001 to 10,000 people.

Where is Queen Mary University of London based?

Queen Mary University of London is headquartered in London, United Kingdom, in the Europe region.

Who are Queen Mary University of London's main competitors?

Direct peers on record are University College London (UCL), Imperial College London, King's College London, University of Cambridge, University of Oxford, London School of Economics and Political Science (LSE), University of Edinburgh, University of Manchester and University of Bristol. University of Warwick is listed as a regional player.

Does Queen Mary University of London have an API?

No public API is recorded for Queen Mary University of London.

What industry is Queen Mary University of London in?

Queen Mary University of London's product category is Higher Education. Its primary akta.pro industry code is EDAHABAA, Comprehensive Doctoral Research Universities (Multi-Disciplinary), with a secondary code of EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 6113 and its SIC code is 8200.